Phreesia, INC Form 4 insider transactions

Allison C. Hoffman, General Counsel & Secretary of Phreesia Inc., sold 3,495 shares of common stock at $24.88 per share on December 18, 2024, under a pre-arranged 10b5-1 trading plan.

David Linetsky, SVP of Life Sciences at Phreesia, Inc., sold 24 shares of common stock to cover tax obligations related to a restricted stock unit settlement.

David Linetsky, SVP of Life Sciences at Phreesia, Inc., sold shares to cover tax obligations related to the settlement of restricted stock units.

Director Michael Weintraub of Phreesia, Inc. sold a total of 21,426 shares of common stock under a pre-arranged 10b5-1 trading plan.

Director Michael Weintraub of Phreesia, Inc. executed a series of stock transactions, including the exercise of stock options and the sale of shares, under a pre-arranged 10b5-1 trading plan.

Phreesia's Senior Vice President, David Linetsky, sold 11,853 shares of common stock at an average price of $24.851 per share, as part of a pre-arranged trading plan.

Phreesia Inc.'s Chief Operating Officer, Evan Roberts, sold 25,000 shares of common stock at an average price of $24.0864 per share, as part of a pre-arranged trading plan.

Amy Beth VanDuyn, SVP of Human Resources at Phreesia Inc., sold 25,447 shares of common stock at a weighted average price of $20.9282 per share.

Phreesia director Michael Weintraub exercised stock options and sold shares on December 2, 2024, under a pre-arranged 10b5-1 trading plan.

Director Gillian Munson acquired 546 shares of Phreesia Inc. common stock through deferred stock units (DSUs) in lieu of a cash retainer.

Director Lainie Goldstein acquired 546 shares of Phreesia, Inc. common stock through the company's Non-Employee Director Deferred Compensation Program.

Director Edward Cahill acquired 546 shares of Phreesia, Inc. common stock at $18.29 per share on October 31, 2024, through deferred stock units.

David Linetsky, SVP of Life Sciences at Phreesia, Inc., sold 1,100 shares of common stock at $20.49 per share under a pre-arranged 10b5-1 trading plan.

Balaji Gandhi, CFO of Phreesia, Inc., sold 864 shares of common stock on October 15, 2024, to cover tax withholding obligations related to the settlement of restricted stock units.

Allison Hoffman, General Counsel & Secretary of Phreesia Inc., sold 1,212 shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.

Phreesia's CEO, Chaim Indig, disposed of shares to cover tax withholding obligations related to the settlement of restricted stock units.

David Linetsky, SVP of Life Sciences at Phreesia, Inc., sold 2,011 shares of common stock to cover tax withholding obligations.

Evan Roberts, Chief Operating Officer of Phreesia Inc., sold 1,843 shares of common stock on October 15, 2024, to cover tax withholding obligations related to the settlement of restricted stock units.

Amy Beth VanDuyn, SVP of Human Resources at Phreesia Inc., sold 624 shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.

Yvonne Hui, Principal Accounting Officer of Phreesia Inc., reported the sale of common stock on October 15 and 16, 2024, according to a Form 4 filing with the SEC.

David Linetsky, SVP of Life Sciences at Phreesia, Inc., sold shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.

David Linetsky, SVP of Life Sciences at Phreesia, Inc., reported selling shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units (RSUs).

Director Lisa Egbuonu-Davis sold 1,400 shares of Phreesia Inc. (PHR) common stock at a price of $23.028 on September 12, 2024.

Balaji Gandhi, CFO of Phreesia, Inc., sold 3,502 shares of common stock on September 10, 2024, to cover tax withholding obligations related to the settlement of restricted stock units.

Yvonne Hui, Principal Accounting Officer of Phreesia Inc., sold 744 shares of common stock on September 10, 2024, to cover tax withholding obligations related to the settlement of restricted stock units (RSUs).

Phreesia's CEO, Chaim Indig, disposed of 5,295 shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.

David Linetsky, SVP of Life Sciences at Phreesia, Inc., sold shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units (RSUs).

Phreesia Inc.'s Chief Operating Officer, Evan Roberts, disposed of 3,148 shares of common stock to cover tax withholding obligations related to the settlement of an RSU award.

Amy Beth VanDuyn, SVP of Human Resources at Phreesia Inc., reported the sale of 737 shares of common stock to cover tax withholding obligations related to the settlement of RSUs.

Allison Hoffman, General Counsel & Secretary of Phreesia, Inc., sold shares of common stock to cover tax obligations and under a pre-arranged 10b5-1 trading plan.